Capital expenditure · 2011–2025
United Therapeutics capital expenditure
$521M+111.2% · FY2025
United Therapeutics (UTHR) reported $521M in capital expenditure for fiscal 2025, +111.2% year on year.
| Fiscal year | Capital expenditure | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $521M | +111.2% | Open → |
| FY20242024-12-31 | $247M | +7.0% | Open → |
| FY20232023-12-31 | $230M | +66.0% | Open → |
| FY20222022-12-31 | $139M | +14.9% | Open → |
| FY20212021-12-31 | $121M | +103.7% | Open → |
| FY20202020-12-31 | $59.3M | −29.2% | Open → |
| FY20192019-12-31 | $83.7M | −54.6% | Open → |
| FY20182018-12-31 | $184M | +113.7% | Open → |
| FY20172017-12-31 | $86.3M | +127.1% | Open → |
| FY20162016-12-31 | $38.0M | −23.7% | Open → |
| FY20152015-12-31 | $49.8M | +5.1% | Open → |
| FY20142014-12-31 | $47.4M | +48.5% | Open → |
| FY20132013-12-31 | $31.9M | −71.5% | Open → |
| FY20122012-12-31 | $112M | +211.0% | Open → |
| FY20112011-12-31 | $36.0M | — | Open → |
Capital expenditure — Capital expenditure is the cash the company spent during the year on property, plant and equipment — factories, stores, servers, vehicles. It appears in the investing section of the cash-flow statement as an outflow and is shown here as a positive amount. Operating cash flow minus this figure is free cash flow.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +21.0%
Capital expenditure at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=United Therapeutics capital expenditure |url=https://companiesranked.com/en/company/united-therapeutics/capital-expenditure |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). United Therapeutics capital expenditure. CompaniesRanked. https://companiesranked.com/en/company/united-therapeutics/capital-expenditureBibTeX
@misc{companiesranked-en-company-united-therapeutics-capital-expenditure-2026,
author = {{CompaniesRanked}},
title = {{United Therapeutics capital expenditure}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/united-therapeutics/capital-expenditure}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001082554-26-000006 · February 25, 2026
{{cite web |title=United Therapeutics capital expenditure — 10-K (0001082554-26-000006) |url=https://www.sec.gov/Archives/edgar/data/1082554/000108255426000006/uthr-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-25}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.